89 related articles for article (PubMed ID: 26418867)
1. Activated Protein C-Resistance Determination and Vascular Access Thrombosis in Populations with High Prevalence of Factor V Leiden.
Androulakis NE; Tzenakis N; Nioti E; Spatharaki P; Vyzoukaki R; Papadopoulou A; Kokonozaki M; Alexandrakis MG
Nephron; 2015; 131(1):5-10. PubMed ID: 26418867
[TBL] [Abstract][Full Text] [Related]
2. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.
Kim TW; Kim WK; Lee JH; Kim SB; Kim SW; Suh C; Lee KH; Lee JS; Seo EJ; Chi HS; Kim SH
J Korean Med Sci; 1998 Dec; 13(6):587-90. PubMed ID: 9886165
[TBL] [Abstract][Full Text] [Related]
3. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
[TBL] [Abstract][Full Text] [Related]
4. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit APC-R Factor V Leiden) at two centers in Europe and the USA.
Schöni R; Quehenberger P; Wu JR; Wilmer M
Thromb Res; 2007; 119(1):17-26. PubMed ID: 16934314
[TBL] [Abstract][Full Text] [Related]
6. Congenital and acquired activated protein C resistance.
Nicolaes GA; Dahlbäck B
Semin Vasc Med; 2003 Feb; 3(1):33-46. PubMed ID: 15199491
[TBL] [Abstract][Full Text] [Related]
7. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
[TBL] [Abstract][Full Text] [Related]
8. Activated protein C resistance in anterior ischaemic optic neuropathy.
Nagy V; Facsko A; Takacs L; Balazs E; Berta A; Balogh I; Edes I; Czuriga I; Pfliegler G
Acta Ophthalmol Scand; 2004 Apr; 82(2):140-3. PubMed ID: 15043529
[TBL] [Abstract][Full Text] [Related]
9. Thrombophilia and the risk for hemodialysis vascular access thrombosis.
Knoll GA; Wells PS; Young D; Perkins SL; Pilkey RM; Clinch JJ; Rodger MA
J Am Soc Nephrol; 2005 Apr; 16(4):1108-14. PubMed ID: 15728780
[TBL] [Abstract][Full Text] [Related]
10. Thrombophilia as a multigenic disease.
Zöller B; García de Frutos P; Hillarp A; Dahlbäck B
Haematologica; 1999 Jan; 84(1):59-70. PubMed ID: 10091393
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: investigation of 507 patients with myocardial infarction.
Middendorf K; Göhring P; Huehns TY; Seidel D; Steinbeck G; Nikol S
Am Heart J; 2004 May; 147(5):897-904. PubMed ID: 15131548
[TBL] [Abstract][Full Text] [Related]
12. [Factor V Leiden and the Slovak population].
Hudecek J; Dobrotová M; Hybenová J; Ivanková J; Melus V; Pullmann R; Kubisz P
Vnitr Lek; 2003 Nov; 49(11):845-50. PubMed ID: 14689680
[TBL] [Abstract][Full Text] [Related]
13. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
Curvers J; Thomassen MC; Rimmer J; Hamulyak K; van der Meer J; Tans G; Preston FE; Rosing J
Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of three reactants for the detection of activated protein C resistance due to mutation of factor V Leiden during pregnancy].
Magdelaine A; Soubrier F; Berkane N; Uzan S; Verdy E
Ann Biol Clin (Paris); 1998; 56(4):445-50. PubMed ID: 9754280
[TBL] [Abstract][Full Text] [Related]
15. Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women.
Tans G; van Hylckama Vlieg A; Thomassen MC; Curvers J; Bertina RM; Rosing J; Rosendaal FR
Br J Haematol; 2003 Aug; 122(3):465-70. PubMed ID: 12877675
[TBL] [Abstract][Full Text] [Related]
16. Resistance to activated protein C in women using oral contraceptives.
Spannagl M; Dick A; Assmann A; Heinemann L; Schramm W
Semin Thromb Hemost; 1998; 24(5):423-30. PubMed ID: 9834008
[TBL] [Abstract][Full Text] [Related]
17. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
[TBL] [Abstract][Full Text] [Related]
18. Association Between Thrombophilic Gene Mutations and the Risk of Vascular Access Thrombosis in Hemodialysis Patients.
Fekih-Mrissa N; Sayeh A; Baffoun A; Beji M; Mrad M; Hmida J; Nsiri B
Ther Apher Dial; 2016 Apr; 20(2):107-11. PubMed ID: 27004938
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of activated protein C resistance (Factor V Leiden) in Lagos, Nigeria.
Adeyemo TA; Adediran A; Akinbami AA; Akanmu AS
Niger J Clin Pract; 2012; 15(2):136-41. PubMed ID: 22718159
[TBL] [Abstract][Full Text] [Related]
20. [Hereditary disorders of the protein C system in central artery and branch arteriolar occlusions].
Greiner K; Hafner G; Prellwitz W; Pfeiffer N
Klin Monbl Augenheilkd; 1999 Jul; 215(1):33-6. PubMed ID: 10448635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]